zosano pharma corp zsanph company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile zosano pharma corp zsanph related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse zsanph on philadelphia stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description zosano pharma corporation incorporated on january   is a clinicalstage specialty pharmaceutical company the company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications its microneedle patch system offers consistent drug delivery and improved ease of use and roomtemperature stability its microneedle patch system has the potential to deliver various medications for a range of indications in commercially attractive marketsthe companys shortweartime transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch when the patch is applied with its handheld applicator the microneedles painlessly penetrate the skin resulting in rapid dissolution and absorption of the drug coating through the capillary bed its product candidates include zptriptan zpglucagon and zppthzppthzppth is a formulation of teriparatide a synthetic form of parathyroid hormone which is referred as pth  or pth which regulates serum calcium to be administered for the treatment of severe osteoporosis osteoporosis is a disease primarily affecting postmenopausal women that is characterized by low bone mineral and structural deterioration of bone tissue which can lead to an increase in bone fractures the company has developed a daily and a weekly dose regimen of zppth and completed a phase ii clinical trial on daily zppth and a phase i clinical trial on weekly zppthzpglucagonzpglucagon is a formulation of glucagon a hormone that raises blood glucose levels intended for the emergency rescue of patients suffering from lifethreatening severe hypoglycemia severe hypoglycemia is a complication of diabetes treatment often caused by insulin overdose characterized by a low level of blood glucose that can lead to loss of consciousness seizure coma and death the company completed a phase i trial of zpglucagon it also completed a phase ii clinical trial in australia to evaluate the performance of zpglucagon product candidate in type  diabetic patients at approximately  mg and one mg doses with induction of hypoglycemia in comparison to comparable doses of glucagon administered by intramuscular injection imzptriptanzptriptan is a formulation of zolmitriptan one of a class of serotonin receptor agonists known as triptans used for the treatment of migraine zptriptan microneedle patch is applied to an individuals upper arm to deliver zolmitriptan to the body with the objective of providing rapid onset relief from headache symptoms the company announced positive results from phase i clinical trial of zptriptan patch which was conducted in healthy human subjects in australia » full overview of zsanph company address zosano pharma corp  ardentech ctfremont   ca    p f  company web links home page officers  directors name compensation john walker  georgia erbez  eric scharin  thorsten von stein  joseph hagan  » more officers  directors zosano pharma corp news briefzosano pharma announces outcome of end of phase  meetings with fda jun   briefzosano pharma appoints john walker as interim ceo may   briefzosano pharma  on may  winnie tso resigned as cfo may   briefzosano announces pricing of public offering of common stock mar   briefzosano pharma files for common stock offering of up to  mln mar   » more zsanph news related topics stocksstock screenerhealthcarebiotechnology  medical research stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  benefits and careers at zosano pharma benefits zosano pharma offers a competitive compensation and benefits package as well as the opportunity to be part of an outstanding organization we strive to provide an exciting challenging and rewarding work environment where each team member is a critical component and contributor to our success health insurance  medical plan options dental plan vision plan ktaxdeferred retirement savings plan flexible investment choices vacations and holidays  vacation days per year  paid holidays per year disability coverage shortterm disability longterm disability life insurance basic life and accidental death and dismemberment add insurance at two times annual base salary business travel insurance pretax flexible spending accounts employees may deposit up to  per year in the dependent care account and up to  per year in the health care account to utilize pretax dollars for reimbursement of approved expenses employee assistance program clinical and work life services careers benefits home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc zosano pharma  migraine treatment  m  zolmitriptan delivering rapid relief are you ready zosano pharma is an emerging cns company focusing on providing rapid symptom relief to patients using known therapeutics with wellestablished safety and efficacy but altering their delivery profile using the company’s proprietary transdermal delivery system the company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action fast acting therapeutic blood levels attained in as early as  minutes simple ready set apply three easy steps for administration safe we use known therapeutics with wellestablished safety and efficacy profiles learn more migraine zosano pharma’s investigational migraine treatment m is a novel formulation of zolmitriptan a drug used orally and nasally to effectively and safely treat migraines administered via the company’s proprietary transdermal delivery system m is being investigated as a potential treatment to provide rapid relief of migraine symptoms at any time in the migraine cycle in a discreet and simple manner learn more recent news june   zosano pharma announces outcome of end of phase  meetings with fda june   zosano announces inducement grants under nasdaq listing rule c june   zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom and sustained pain freedom view all news home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc publications from zosano pharma  transdermal drug delivery  migraine patents  publications zosano pharma has a strong platform of both technology and product specific intellectual property zosano pharma has secured  specific patent families we continue to build our patent estate on a global basis selected publications randomized doubleblind multicenter parallelgroup evaluation of the safety and efficacy of adam zolmitriptan for the acute treatment of migraine elh spierings jl brandes db kudrow j weintraub j rubino dj kellerman sj tepper pharmacokinetics and tolerability of a new intracutaneous microneedle system of zolmitriptan zpzolmitriptan donald kellerman jason lickliter jacquie mardell thorsten von stein pdf human growth hormone delivery with a microneedle transdermal system preclinical formulation stability delivery and pk of therapeutically relevant doses  m ameri m kadkhodayan  j nguyen  ja bravo  r  su  k chan  a samiee pe daddona pharmaceutics   erythropoietincoated zpmicroneedle transdermal system preclinical formulation stability and delivery elaine e peters  mahmoud ameri  xiaomei wang  yuhfun maa  peter e daddona pharmaceutical research  parathyroid hormone coated microneedle patch system clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis  peter e daddona james a matriano jaap mandema yuhfun maa pharmaceutical research  effect of transdermal teriparatide administration on bone mineral density in postmenopausal women  e lane michael a bolognese jose r zanchetta pedro a garciahernandez karen sees james a matriano kim gaumer peter e daddona journal of clinical endocrinolology  metabolism   parathyroid hormone pth formulation that enables uniform coating on a novel transdermal microprojection delivery system mahmoud ameri shelley c fan yuhfun maa pharmaceutical research    effect of irradiation on parathyroid hormone pth coated on a novel transdermal microprojection delivery system to produce a sterile productadhesive compatibility mahmoud ameri xiaomei wang yuhfun maa journal of pharmaceutical science    demonstrated solidstate stability of parathyroid hormone pth– coated on a novel transdermal microprojection delivery system  mahmoud ameri peter e daddona yuhfun maa pharmaceutical research   effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system georg widera juanita johnson lomi kim luz libiran kofi nyam peter e daddona michel cormier vaccine    transdermal delivery of desmopressin using a coated microneedle array patch system michel cormier bonny johnson mamoud ameri kofi nyam luz libiran dee dee zhang and pete daddona journal of controlled release    transdermal delivery of antisense oligonucleotides weiqi lin michel cormier and peter e daddona celluar drug delivery principles and practice humana press  transdermal drug delivery brad phipps michel cormier bob gale bill van osdal jay audett rama padmanabhan and peter daddona encyclopedia of biomaterials and biomedical engineering marcel dekker inc new york   macroflux® transdermal technology development for the delivery of therapeutic peptides  proteins pete daddona phd drug delivery technology    macroflux® microprojection array patch technology a new and efficient approach for intracutaneous immunization james a matriano michel cormier juanita johnson wendy a young margaret buttery kofi nyam and peter e daddona pharmaceutical research vol    macroflux® technology for transdermal delivery of therapeutic proteins and vaccines michel cormier and peter e daddona modifiedrelease drug delivery technology marcel dekker inc new york   transdermal delivery of antisense oligonucleotides with microprojection patch macroflux® technology weiqi lin michel cormier amad samiee angie griffin bonny johnson chingleou teng gregory e hardee and peter e daddona pharmaceutical research    technology pipeline publications home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  analyst coverage  zosano pharma analyst coverage zosano pharma is covered by the following analysts analyst coverage firm analyst piper jaffray  co charles c duncan phd charlescduncanpjccom phone  roth capital partners scott r henry cfa shenryrothcom phone  please note that any opinions estimates or forecasts regarding zosano pharmas performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of zosano pharma or its management zosano pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information conclusions or recommendations shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc  fiercepharma skip to main content twitter linkedin search  any homepagepharmamaregulatoryfinancialscorporatelegalmanufacturingmaoutsourcingregulatorysupply chaindrug safetypartneringmarketingregulatorydtc advertisingdigital and social mediadata and analyticslaunchespharma asiamamanufacturingrdregulatorysales and marketingfinancialsanimal healthmardregulatoryveterinarianfinancialsvaccinesdrug deliveryrdregulatorypartneringvaccinesdealsinfectious diseasesrdregulatory sort by published date order oldestnewest eventfiercebiotech nd drug development forumseptember    boston ma  sponsored by fiercebiotech join  csuite biotech executives at the unmatched educational venue for drug development professionals this event will cover the greatest partnership challenges that biotech companies face throughout the entire product and corporate development cycle to learn more or register click here more info popular content astrazenecas mystic shortfall is an immunooncology shakeup for bristolmyers and a bolster for merck and roche jul   new glaxosmithkline chief walmsley makes early mark with sweeping pharma overhaul jul   astrazeneca merck team up on lynparza combos in collaboration worth up to b jul   roche’s deep discount for ms drug ocrevus pays off big for swiss drugmaker jul   lillys baricitinib setback gives pfizers xeljanz a clear shot at newer rivals jul    fiercepharma skip to main content twitter linkedin search  any ebookebriefeventexecutive summaryjobmultimediapaid marketplaceresearchsurveyvideowebinarwhitepaper  any homepagepharmamaregulatoryfinancialscorporatelegalmanufacturingmaoutsourcingregulatorysupply chaindrug safetypartneringmarketingregulatorydtc advertisingdigital and social mediadata and analyticslaunchespharma asiamamanufacturingrdregulatorysales and marketingfinancialsanimal healthmardregulatoryveterinarianfinancialsvaccinesdrug deliveryrdregulatorypartneringvaccinesdealsinfectious diseasesrdregulatory sort by published date order oldestnewest webinarexploring adc pharmacokinetics using qsp modeling strategiesseptember    pm et  am pt  presented by applied biomath the pharmacokinetics pk of adc therapeutics typically show a discrepancy between the pk of total antibody and that of conjugated antibody carrying one or more payload molecules this will present how quantitative systems pharmacology modeling approaches provide biological insights into the impact of drugtoantibody ratio and the resulting changes in molecular properties on overall pk and relative payload disposition as observed in preclinical and clinical studies register now more info webinar small size big plans – product development advice for small companiesaugust    pm etam pt  presented by rho this webinar will provide advice on how to set your small company up for longterm success through the use of strategic development plans purposeful outsourcing patent protection partnership strategies and provide specific examples of success stories and lessons learned register now more info webinarmagnify patient engagement productivity with unified cognitive search on salesforceaugust    pm et  am pt  presented by persistent systems obtain greater productivity and effectiveness in the matters of patient and member engagement this webinar will present the packaged solution that enables single window proactive access within the salesforce service console for customer service representatives  supervisors to effectively manage their patient and member populations register now more info webinaraccelerate clinical trials with rapid application developmentaugust     pm et   am pt  presented by salesforce clinical trials are at a crossroads biopharmaceutical companies must accelerate the development and approval of tailored therapeutics but legacy clinical it infrastructure makes it difficult to keep up this webinar will highlight how life science companies are building connected rd applications using an agile intelligent platform that connects key stakeholders including sponsors cros sites and subjects learn from customer success stories and live demonstrations and see how you can apply this approach to turbocharge your own clinical programs register now more info webinarbring your life sciences content management strategy into the digital ageaugust    pm et  am pt  presented by medidata solutions the life sciences industry is undergoing a digital transformation as legacy it systems move into the cloud and cohesive transition strategies are required whether you’re in quality control clinical operations it regulatory compliance or manage another area of the trial join medidata and box explore how to build a total regulated and nonregulated content management strategy to match todays unique challenges including implementing technology via a single userfriendly platform register now more info webinarimplementing a common data model in a realworld analytics environmentsponsored by evidera this webinar “implementing a common data model cdm in a realworld informatics and analytics environment headwinds or smooth sailing” explores cdm research vs practice and the issues encountered when implementing a cdm in practice including alternative approaches and potential best practices watch now more info whitepaperrealworld evidence in payer negotiations – what’s in your playbooksponsored by evidera realworld evidence plays an important role in acquiring and defending optimal payer position read our white paper on the use of rwe to align with payers on environment  value vs competitors at launch defend payer positioning and potentially bolster and extend the value of onmarket products more info webinarhow modern quality systems are transforming change managementnow ondemand  presented by veeva assessing impact and creating and executing a change plan are difficult with global stakeholders and multitude of systems during this webinar learn frameworks and best practices for transforming change management register now more info webinarconnecting the drug development journey with datadriven insightsjuly    am et  am pt  presented by parexel while biopharmaceutical companies face challenges in generating and integrating meaningful insights that drive timely and actionable decisions aggregating and leveraging the right data to drive value requires a broad range of services working together to generate insights across the entire drug development spectrum hear parexel experts derive datadriven insights and how these insights can benefit many essential drug development areas register now more info webinaraccelerate your speed to market new options for generic drug packaging  deliverynow available ondemand  presented by west pharmaceutical services quality speed simplicity learn how a new elastomeric closure formulation turnkey extractables and leachables package and a flexible supply can help generics manufacturers make the move to market join this webinar with west experts and learn about generics market trends and acceltra™ brand program attributes that address generic injectable drug manufacturer issues and ensure a fast move to market register now more info popular content astrazenecas mystic shortfall is an immunooncology shakeup for bristolmyers and a bolster for merck and roche jul   new glaxosmithkline chief walmsley makes early mark with sweeping pharma overhaul jul   astrazeneca merck team up on lynparza combos in collaboration worth up to b jul   roche’s deep discount for ms drug ocrevus pays off big for swiss drugmaker jul   lillys baricitinib setback gives pfizers xeljanz a clear shot at newer rivals jul   zsan key statistics  zosano pharma corp financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close zosano pharma corp nasdaq zsan go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus zosano pharma corp market closed  quotes are delayed by  min jul    pm zsan quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description zosano pharma corp is a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system it offers rapid absorption of drug consistent drug delivery improved ease of use and roomtemperature stability benefits that differentiate its delivery platform from other non zosano pharma corp is a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system it offers rapid absorption of drug consistent drug delivery improved ease of use and roomtemperature stability benefits that differentiate its delivery platform from other nonoral formulations or injections the company was founded in january  and is headquartered in fremont ca valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  total debt to enterprise value  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title ms georgia l erbez   chief financial  business officer dr donald j kellerman   vpclinical development  medical affairs mr eric scharin   vice presidentengineering  operations mr bruce d steel   director mr hayley lewis   vice presidentregulatory affairs  quality insider actions – purchase – sale  – number of transactions  date name shares transaction value  john p walker interim ceo director    acquisition at  per share   georgia l erbez cfo and chief business officer    acquisition at  per share   john p walker interim ceo director    acquisition at  per share   john p walker interim ceo director    award at  per share   john p walker interim ceo director    derivativenonderivative trans at  per share   konstantinos alataris president ceo director    derivativenonderivative trans at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share   new enterprise associates llc    disposition at  per share  newslatestcompanyuszsan marketwatch news on zsan zosana pharmas stock rockets after migraine patch produces positive trial results  am feb    tomi kilgore zosano pharmas stock rockets  premarket after trial results of pain treatment  am feb    tomi kilgore zosano pharma downgraded to neutral from buy at ladenburg thalmann  am aug    tomi kilgore newsnonmarketwatchcompanyuszsan other news on zsan roty edition  volume  updates and several trades  am july    seeking alpha roty edition  volume  our first sell  am july    seeking alpha roty edition  volume  insider buying updates and the gunshot technology coming to a city near you  am july    seeking alpha roty edition  volume  conviction insider buying regulatory feedback and trades  am june    seeking alpha roty edition  volume  updates and format changes  am june    seeking alpha roty edition  volume  position updates and new trades  am june    seeking alpha weekly cfo buys highlight  pm may    gurufocuscom roty edition  volume  introducing a migraine play that could double in the near term  am may    seeking alpha zosano pharma corp zsan interim ceo john peter walker bought  of shares  pm may    gurufocuscom zosano up  premarket after execs buy shares  am may    seeking alpha zosano pharma corp zsan interim ceo john peter walker bought  of shares  pm may    gurufocuscom zosano pharmas zsan ceo john walker on q  results  earnings call transcript  pm may    seeking alpha q zosano pharma corp  pm may    edgar online  edg  q k  drug stocks that could be big winners this earnings season  am april    zackscom premarket analyst action  healthcare  am march    seeking alpha k zosano pharma corp  am march    edgar online  edg  q k zosano pharma there is more upside despite recent runup  am feb    seeking alpha premarket analyst action  healthcare  am feb    seeking alpha zosanos lead product candidate successful in latestage migraine study shares ahead  premarket  am feb    seeking alpha zosano pharma divests zosano inc to foreign investors  pm nov    seeking alpha loading more headlines at a glance zosano pharma corp  ardentech court fremont california  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for zsan newspressreleasecompanyuszsan press releases on zsan zosano pharma announces outcome of end of phase  meetings with fda  am june    globenewswire zosano announces inducement grants under nasdaq listing rule c  pm june    globenewswire zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom and sustained pain freedom  am june    globenewswire zosano to present migraine data at three industryleading conferences  am june    globenewswire todays research reports on stocks to watch biodelivery sciences international and zosano pharma  am may    accesswire biotech stocks under scanner  bioverativ zosano pharma mannkind and ocera therapeutics  am may    pr newswire  prf zosano reports first quarter  financial results and announces management changes  pm may    globenewswire investor network zosano pharma corp to host earnings call  pm may    accesswire zosano pharma to host conference call on first quarter  financial results and provide operational update  am may    globenewswire zosano announces closing of public offering of common stock and exercise of underwriters overallotment option  pm march    globenewswire zosano announces pricing of public offering of common stock  am march    globenewswire technical reports on biotech stocks  bioverativ pulmatrix pharmathene and zosano pharma  am march    pr newswire  prf zosano pharma reports fourth quarter and fiscal  financial results and business update  am march    globenewswire biotech industry shaping up to have a breakout year in  todays reports on insys therapeutics and zosano pharma  am feb    accesswire zosano pharma announces mg dose of m its novel transdermal therapeutic meets both coprimary endpoints in the zotrip pivotal efficacy trial in migraine  am feb    globenewswire zosano announces inducement grant under nasdaq listing rule c  pm jan    globenewswire zosano pharma announces last subject treated in its migraine pivotal trial  am jan    globenewswire zosano pharma announces sale of nonstrategic asset  pm nov    globenewswire peptide therapeutics in metabolic disorders     am nov    pr newswire  prf zosano pharma reports third quarter  financial results  pm nov    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  zsan stock price  zosano pharma corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states zsan overview compare quotes stock screener earnings calendar sectors nasdaq zsan us nasdaq join td ameritrade find a broker zosano pharma corp watchlist createzsanalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones zosana pharmas stock rockets after migraine patch produces positive trial results feb   at  am et by tomi kilgore zosano pharmas stock rockets  premarket after trial results of pain treatment feb   at  am et by tomi kilgore zosano pharma downgraded to neutral from buy at ladenburg thalmann aug   at  am et by tomi kilgore no headlines available recent news other news press releases roty edition  volume  updates and several trades roty edition  volume  updates and several trades jul   at  am et on seeking alpha roty edition  volume  our first sell roty edition  volume  our first sell jul   at  am et on seeking alpha roty edition  volume  insider buying updates and the gunshot technology coming to a city near you roty edition  volume  insider buying updates and the gunshot technology coming to a city near you jul   at  am et on seeking alpha roty edition  volume  conviction insider buying regulatory feedback and trades roty edition  volume  conviction insider buying regulatory feedback and trades jun   at  am et on seeking alpha roty edition  volume  updates and format changes roty edition  volume  updates and format changes jun   at  am et on seeking alpha roty edition  volume  position updates and new trades roty edition  volume  position updates and new trades jun   at  am et on seeking alpha weekly cfo buys highlight weekly cfo buys highlight may   at  pm et on gurufocuscom roty edition  volume  introducing a migraine play that could double in the near term roty edition  volume  introducing a migraine play that could double in the near term may   at  am et on seeking alpha zosano pharma corp zsan interim ceo john peter walker bought  of shares zosano pharma corp zsan interim ceo john peter walker bought  of shares may   at  pm et on gurufocuscom zosano up  premarket after execs buy shares zosano up  premarket after execs buy shares may   at  am et on seeking alpha zosano pharma corp zsan interim ceo john peter walker bought  of shares zosano pharma corp zsan interim ceo john peter walker bought  of shares may   at  pm et on gurufocuscom zosano pharmas zsan ceo john walker on q  results  earnings call transcript zosano pharmas zsan ceo john walker on q  results  earnings call transcript may   at  pm et on seeking alpha q zosano pharma corp q zosano pharma corp may   at  pm et on edgar online  edg  q k zosano pharma corp zsan announces q results and ceo change shares tumble zosano pharma corp nasdaqzsan reported financial results for the first quarter ended march   in  may   at  pm et on smarteranalyst  drug stocks that could be big winners this earnings season apr   at  am et on zackscom premarket analyst action  healthcare mar   at  am et on seeking alpha k zosano pharma corp mar   at  am et on edgar online  edg  q k zosano pharma there is more upside despite recent runup feb   at  am et on seeking alpha premarket analyst action  healthcare feb   at  am et on seeking alpha zosanos lead product candidate successful in latestage migraine study shares ahead  premarket feb   at  am et on seeking alpha zosano pharma announces outcome of end of phase  meetings with fda zosano pharma announces outcome of end of phase  meetings with fda jun   at  am et on globenewswire zosano announces inducement grants under nasdaq listing rule c zosano announces inducement grants under nasdaq listing rule c jun   at  pm et on globenewswire zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom and sustained pain freedom zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom and sustained pain freedom jun   at  am et on globenewswire todays research reports on stocks to watch biodelivery sciences international and zosano pharma todays research reports on stocks to watch biodelivery sciences international and zosano pharma may   at  am et on accesswire biotech stocks under scanner  bioverativ zosano pharma mannkind and ocera therapeutics biotech stocks under scanner  bioverativ zosano pharma mannkind and ocera therapeutics may   at  am et on pr newswire  prf investor network zosano pharma corp to host earnings call investor network zosano pharma corp to host earnings call may   at  pm et on accesswire zosano pharma to host conference call on first quarter  financial results and provide operational update zosano pharma to host conference call on first quarter  financial results and provide operational update may   at  am et on globenewswire zosano announces closing of public offering of common stock and exercise of underwriters overallotment option mar   at  pm et on globenewswire zosano announces pricing of public offering of common stock mar   at  am et on globenewswire technical reports on biotech stocks  bioverativ pulmatrix pharmathene and zosano pharma mar   at  am et on pr newswire  prf zosano pharma reports fourth quarter and fiscal  financial results and business update mar   at  am et on globenewswire biotech industry shaping up to have a breakout year in  todays reports on insys therapeutics and zosano pharma feb   at  am et on accesswire zosano pharma announces mg dose of m its novel transdermal therapeutic meets both coprimary endpoints in the zotrip pivotal efficacy trial in migraine feb   at  am et on globenewswire zosano announces inducement grant under nasdaq listing rule c jan   at  pm et on globenewswire zosano pharma announces last subject treated in its migraine pivotal trial jan   at  am et on globenewswire zosano pharma announces sale of nonstrategic asset nov   at  pm et on globenewswire peptide therapeutics in metabolic disorders    nov   at  am et on pr newswire  prf zosano pharma reports third quarter  financial results nov   at  pm et on globenewswire zosano pharma announces completion of enrollment in pivotal efficacy trial for m for acute migraine nov   at  am et on globenewswire shareholder notice khang  khang llp announces an investigation of zosano pharma corporation and encourages investors with losses to contact the firm oct   at  pm et on accesswire zosano pharma corp zosano pharma corp is a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system it offers rapid absorption of drug consistent drug delivery improved ease of use and roomtemperature stability benefits that differentiate its delivery platform from other nonoral formulations or injections the company was founded in january  and is headquartered in fremont ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top downgrades aug   at  am et on benzingacom ladenburg thalmann downgrades zosano pharma to neutral on financing overhang market uncertainty aug   at  am et on benzingacom competitors name chg  market cap endologix inc  m baxter international inc  b spectral medical inc  m neurometrix inc  m competitor data provided by partner content trending tickers powered by dvax  sq  wfc  csco  ben  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft investor relations  zosano pharma investor relations zosano pharma is an emerging cns company focusing on providing rapid symptom relief to patients using known therapeutics with wellestablished safety and efficacy but altering their delivery profile using the company’s proprietary transdermal delivery system the company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action nasdaq zsan     day high  day low   volume      pm et on jul   delayed at least  minutes  mo  mo  yr press releases jun   zosano pharma announces outcome of end of phase  meetings with fda jun   zosano announces inducement grants under nasdaq listing rule c view all events  presentations upcoming events are not available at this time sign up for email alerts view all shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc investor relations  zosano pharma investor relations zosano pharma is an emerging cns company focusing on providing rapid symptom relief to patients using known therapeutics with wellestablished safety and efficacy but altering their delivery profile using the company’s proprietary transdermal delivery system the company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action nasdaq zsan     day high  day low   volume      pm et on jul   delayed at least  minutes  mo  mo  yr press releases jun   zosano pharma announces outcome of end of phase  meetings with fda jun   zosano announces inducement grants under nasdaq listing rule c view all events  presentations upcoming events are not available at this time sign up for email alerts view all shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one investor faqs  zosano pharma investor faqs   show all on what stock exchange are zosano pharmas shares traded and what is the ticker symbol the zosano pharma ticker is zsan and it is traded on the nasdaq capital market when was zosano pharmas initial public offering ipo zosano pharma’s ipo was on january   who were the managing underwriters for zosano pharmas ipo the underwriters for the ipo were ladenburg thalmann and roth capital partners who are the members of zosano pharmas board of directors you can view our board of directors by visiting the board of directors section of our investor relations website who are the members of the zosano pharmas management team you can view our management team by visiting the management section of our investor relations website when does zosano pharmas fiscal year end zosano pharma’s fiscal year ends on december st who are the companys independent registered public accountants marcum llp does zosano pharma pay dividends zosano pharma does not expect to declare or pay any cash or other dividends on our common stock as we intend to reinvest cash flow generated by operations in our business who is zosano pharmas transfer agent computershare whom do i contact with questions about my stock computershare investor centre wwwcomputersharecominvestor email webqueriescomputersharecom telephone inquiries  written requests computershare po box  college  station tx  how do i transfer stock change the address on my shareholder account or replace a lost stock certificate please contact computershare investor centre webqueriescomputersharecom or call  does zosano pharma have a direct stock purchase plan zosano pharma does not currently have a direct stock purchase plan where can i find all of zosano pharmas sec filings where can i download and view quarterly and annual reports quarterly and annual reports as well as other sec filings can be accessed on the financial information portion of our investor relations website or directly from the sec at wwwsecgov how do i contact investor relations with a question or request you can contact zosano pharma’s investor relations via email at jjonesbplifesciencecom in addition you can reach investor relations by calling  x  do you have another question that hasnt been answered please submit your question using the form below  indicates required field name email subject comments listen to audio version type in number submit comment shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc stock information  zosano pharma stock information stock quote zsan      pm et on jul   previous close  open  volume  exchange nasdaq day high  day low  week high  week low  stock chart compare benchmark nasdaq nyse sp  amex benchmark area graph ohlc line graph candlestick time intraday  day  month  month  months  year  years  years  years range update from to   the stock information provided is for informational purposes only and is not intended for trading purposes the stock information is provided by esignal stock charts are provided by edgar online both third party services and zosano pharma does not maintain or provide information directly to this service stock information is delayed approximately  minutes sign up for email alerts the stock information provided is for informational purposes only and is not intended for trading purposes the stock information is provided by esignal stock charts are provided by nasdaq omx both third party services and zosano pharma does not maintain or provide information directly to this service stock information is delayed approximately  minutes shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc press releases  zosano pharma press releases year all years            sort by date descending date ascending update   press releases   date title and summary view jun   zosano pharma announces outcome of end of phase  meetings with fda confirmation of previously announced design of longterm safety studyrecently completed zotrip study acknowledged sufficient for nda filingcmc development strategy confirmed adequate for registration fremont calif june   globe newsw pdf add to briefcase file is in briefcase jun   zosano announces inducement grants under nasdaq listing rule c fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients using our proprietary adam technology today announced that it has approved inducement option grants to two new empl pdf add to briefcase file is in briefcase jun   zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom and sustained pain freedom fremont calif june   globe newswire  zosano pharma inc nasdaqzsan zosano or the company a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients using our proprietary adam technology presented additional data from its pivotal phase  zotrip study eval pdf add to briefcase file is in briefcase jun   zosano to present migraine data at three industryleading conferences latebreaking oral and oral presentations to feature m acute migraine therapy zotrip pivotal trial data selected by headache society and drug delivery meetings fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a specialty  pdf add to briefcase file is in briefcase may   zosano reports first quarter  financial results and announces management changes pivotal trial of m meets coprimary endpoints to establish fast and durable pain relief million followon offering of common stock provides funding for initiating required safety study and meeting precommercialization cmc manufacturing criteriazosano names john p walker interim ceo pdf add to briefcase file is in briefcase may   zosano pharma to host conference call on first quarter  financial results and provide operational update fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan an emerging central nervous system company focused on providing symptom relief to patients using the companys proprietary intracutaneous delivery system today announced that it will host a conference call and webcast to be held on tuesday may    pdf add to briefcase file is in briefcase mar   zosano announces closing of public offering of common stock and exercise of underwriters overallotment option fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on developing an acute migraine treatment with a differentiated efficacy profile using the companys proprietary transdermal delivery system today announced the closing of the previously announced public offering of  pdf add to briefcase file is in briefcase mar   zosano announces pricing of public offering of common stock fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on developing an acute migraine treatment with a differentiated efficacy profile using the companys proprietary transdermal delivery system today announced the pricing of an underwritten public offering o pdf add to briefcase file is in briefcase mar   zosano pharma reports fourth quarter and fiscal  financial results and business update fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan an emerging central nervous system company focused on providing symptom relief to patients using the companys proprietary intracutaneous delivery system today announced financial results for the fourth quarter and year ended december  pdf add to briefcase file is in briefcase feb   zosano pharma announces mg dose of m its novel transdermal therapeutic meets both coprimary endpoints in the zotrip pivotal efficacy trial in migraine  of patients experienced freedom from pain at  hours vs  for placebo p  of patients experienced freedom from most bothersome symptom at  hours vs  for placebo p  of patients experienced freedom from pain at  hour vs   pdf add to briefcase file is in briefcase jan   zosano announces inducement grant under nasdaq listing rule c fremont calif jan   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on providing rapid symptom relief to patients using the companys proprietary transdermal delivery system today announced that it has approved an inducement grant of options to purchase  shares of the companys  pdf add to briefcase file is in briefcase jan   zosano pharma announces last subject treated in its migraine pivotal trial fremont calif jan   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced that the last subject has been treated in the companys registrationenabling pivotal effica pdf add to briefcase file is in briefcase nov   zosano pharma announces sale of nonstrategic asset fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan an emerging central nervous system company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced that it has sold all of its interest in zosano inc for an aggregate cash pdf add to briefcase file is in briefcase nov   zosano pharma reports third quarter  financial results fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan an emerging central nervous system company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced financial results for the third quarter ended september   pdf add to briefcase file is in briefcase nov   zosano pharma announces completion of enrollment in pivotal efficacy trial for m for acute migraine fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced completion of enrollment in its registrationenabling pivotal efficacy trial the zotrip tri pdf add to briefcase file is in briefcase sep   zosano announces inducement grant for georgia erbez chief business officer fremont calif sept   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on providing rapid symptom relief to patients using the companys proprietary transdermal delivery system today announced that it has approved an inducement grant of options to purchase  shares of t pdf add to briefcase file is in briefcase sep   zosano appoints georgia erbez as chief business officer fremont calif sept   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on providing rapid symptom relief to patients using the companys proprietary transdermal delivery system today announced the appointment of ms georgia erbez as its chief business officer effective september pdf add to briefcase file is in briefcase aug   zosano pharma announces pricing of private placement of common stock and warrants fremont calif aug   globe newswire  zosano pharma corporation nasdaqzsan a cns company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced that it has entered into a securities purchase agreement to sell shares of its common stock and warrant pdf add to briefcase file is in briefcase aug   zosano pharma reports second quarter  financial results fremont calif aug   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focused on providing rapid symptom relief to patients using the companys proprietary intracutaneous delivery system today announced financial results for the second quarter ended june   with the recent  pdf add to briefcase file is in briefcase jul   first subject treated in zosano pharmas pivotal efficacy trial for m patch for acute migraine fremont calif july   globe newswire  zosano pharma corporation nasdaqzsan an emerging cns company focusing on providing rapid symptom relief to patients using the companys proprietary transdermal delivery system today announced the dosing of its first subject in its registrationenabling pivotal efficacy trial the zotrip pdf add to briefcase file is in briefcase jun   zosano pharma enrolls first subject in pivotal clinical trial for zptriptan patch program for treatment of migraine fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs today announced the enrollment of its first subject in a pivotal efficacy trial of its zptriptan patch treatment for acute mi pdf add to briefcase file is in briefcase may   zosano pharma reports first quarter  financial results fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs today announced financial results for the first quarter ended march   zosano is making progress towards initiating ou pdf add to briefcase file is in briefcase may   zosano announces appointment of john p walker as chairman of the board fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs announced today that it named mr john p walker chairman of the boardwe are honored to have john joining us at such a transfor pdf add to briefcase file is in briefcase may   zosano pharma to report first quarter  financial results fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan today announced that it plans to report financial results for the first quarter of  on thursday may   zosano will host a conference call and webcast to provide an update at  pm et  pm pt that day the call will be hos pdf add to briefcase file is in briefcase mar   zosano pharma reports fourth quarter and  financial results and business update fremont cali march   globe newswire  zosano pharma corporation nasdaqzsan a clinical stage specialty pharmaceutical company with proprietary microneedle patch technology for the delivery of drugs through the skin today announced financial results for the fourth quarter and year ended december   the company also pro pdf add to briefcase file is in briefcase mar   zosano pharma to report fourth quarter and  financial results and to provide a corporate update fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan today announced that it plans to report financial results for the fourth quarter and full year  on tuesday march   zosano will host a conference call and webcast to provide a corporate update at  pm et  pm pt that day the cal pdf add to briefcase file is in briefcase mar   zosano pharma to present at the th annual roth conference fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company today announced that konstantinos alataris phd president and chief executive officer of zosano will provide a company overview at the th annual roth conference on march   the presentat pdf add to briefcase file is in briefcase jan   zosano pharma announces appointment of konstantinos alataris phd as president and chief executive officer fremont calif jan   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage pharmaceutical company today announced the appointment of konstantinos alataris phd as president and chief executive officer effective immediately dr alataris currently serves as the companys president and chief operating offi pdf add to briefcase file is in briefcase nov   zosano pharma to present at the stifel  healthcare conference fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan announced today that vikram lamba chief executive officer will provide a company overview at the stifel  healthcare conference on november   the presentation will take place from  to  pm et at the new york palace hotel in new yo pdf add to briefcase file is in briefcase nov   zosano pharma reports third quarter  financial results fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company today announced financial results for the three months ended september   we had a very eventful third quarter with updates on all programs we are particularly pleased with our  pdf add to briefcase file is in briefcase nov   zosano pharma to announce third quarter  financial results host conference call and live webcast on november   fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company announced today that it will release its thirdquarter  financial results on monday november   in connection with the earnings release zosano pharma will host a conference call an pdf add to briefcase file is in briefcase nov   zosano pharma announces positive phase  results for its zptriptan patch program for treatment of migraine fremont calif nov   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company today announced positive results from the phase  clinical trial of its proprietary zptriptan patch treatment for migrainezptriptan is a zolmitriptancoated microneedle patch that is app pdf add to briefcase file is in briefcase oct   zosano pharma announces positive phase  results for its zpglucagon patch program for treatment of severe hypoglycemia fremont calif oct   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company today announced positive results from the phase  clinical trial of its proprietary rapid onset transdermal zpglucagon patch for severe hypoglycemia the obj pdf add to briefcase file is in briefcase sep   zosano pharma resumes development of weekly zppth treatment for severe osteoporosis company announces discontinuation of development of daily zppth and terminates collaboration with eli lilly and company zosano to host webcast and conference call today at  pm et fremont calif sept   globe newswire  zosano pharma corporation nasdaqzsan announced today that the company has decided to discontinue developm pdf add to briefcase file is in briefcase sep   zosano pharma to present at the ladenburg thalmann  healthcare conference fremont calif sept   globe newswire  zosano pharma corporation nasdaqzsan announced today that vikram lamba chief executive officer will provide a company overview at the ladenburg thalmann  healthcare conference on september   the presentation will take place at  pm et at the sofitel hotel in new york new yor pdf add to briefcase file is in briefcase sep   zosano pharma announces new executive appointment and management change fremont calif sept   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin today announced management changes reflecting the evolution of the business from a rdorie pdf add to briefcase file is in briefcase sep   zosano pharma completes enrollment in phase  study for microneedle patch delivery of zolmitriptan for the treatment of migraine fremont calif sept   globe newswire  zosano pharma corporation nasdaq zsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver therapeutics conveniently through the skin for the treatment of a variety of indications announced today that it has complete pdf add to briefcase file is in briefcase aug   zosano pharma reports second quarter  financial results fremont calif aug   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin today announced financial results for the three months ended june   we are ple pdf add to briefcase file is in briefcase jul   zosano pharma expands clinical  regulatory teams with three strategic hires fremont calif july   globe newswire  zosano pharma corporation nasdaqzsan announced today important leadership additions with the hiring of donald kellerman pharmd as vice president clinical development david zhang phd as executive director biostatistics and data management and jacquie mardell as senior director clinical pdf add to briefcase file is in briefcase jul   zosano pharma announces discontinuation of novo nordisk glp patch collaboration fremont calif july   globe newswire  zosano pharma corporation nasdaqzsan announced today that novo nordisk nvo has notified zosano of its intention to discontinue the collaboration agreement related to development of a transdermal presentation of select nvo glucagonlike peptide glp analogues zosano has been notified that  pdf add to briefcase file is in briefcase jun   zosano pharma to present at the cantor fitzgerald inaugural healthcare conference fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan announced today that vikram lamba chief executive officer will provide a company overview at the cantor fitzgerald inaugural healthcare conference on july   the presentation will take place at  pm et at the le parker meridien hotel in new york pdf add to briefcase file is in briefcase jun   zosano announces  million debt financing fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver therapeutics conveniently through the skin for the treatment of a variety of indications today announced that it has secured  pdf add to briefcase file is in briefcase jun   zosano pharma completes enrollment in phase  trial for zpglucagon its microneedle patch for treatment of severe hypoglycemia fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver therapeutics conveniently through the skin for the treatment of a variety of indications today announced that it has completed pdf add to briefcase file is in briefcase may   zosano pharma appoints joseph p hagan to board of directors fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver therapeutics conveniently through the skin for the treatment of a variety of indications today announced the election of joseph pdf add to briefcase file is in briefcase may   zosano pharma reports first quarter  financial results fremont calif may   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications today announced financial results for the thre pdf add to briefcase file is in briefcase apr   zosano pharma appoints new cmo fills two new operations management positions to bolster leadership team fremont calif april   globe newswire  zosano pharma corporation nasdaqzsan announced today important leadership additions and changes with thorsten von stein md phd returning to the company as chief medical officer laxmi peri joining as sr vice president operations and eric scharin joining as vice president technical ope pdf add to briefcase file is in briefcase mar   zosano pharma reports  financial results fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan a clinicalstage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications today announced financial results for the ye pdf add to briefcase file is in briefcase mar   zosano pharma to present at the th annual roth conference fremont calif march   globe newswire  zosano pharma corporation nasdaqzsan announced today that vikram lamba chief executive officer will provide a company overview at the th annual roth conference on march   the presentation will take place at  am pt at the ritz carlton hotel in laguna niguel california to a pdf add to briefcase file is in briefcase jan   zosano pharma announces pricing of initial public offering fremont calif jan   globe newswire  zosano pharma corporation nasdaq zsan announced today the pricing of its initial public offering of  shares of common stock at a price to the public of  per share the shares are scheduled to begin trading on the nasdaq capital market under the ticker symbol zsan on january   pdf add to briefcase file is in briefcase dec   zosano pharma and eli lilly and company enter into exclusive licensing agreement for zosanos zppth product candidate fremont calif and indianapolis dec   globe newswire  zosano pharma corporation zosano and eli lilly and company nyselly today announced that they have entered into an exclusive agreement to develop zppth zosanos proprietary formulation of parathyroid hormone  pth using zosanos microneedle patch system for the treatment  pdf add to briefcase file is in briefcase jun   zosano pharma appoints troy wilson phd jd to board of directors fremont california june    zosano pharma corporation a privately held pharmaceutical company developing products based on its novel transdermal delivery technology today announced the election of troy wilson phd jd to its board of directors dr wilson has more than  years of experience in the biotechnology industry and a  pdf add to briefcase file is in briefcase jun   zosano pharma files registration statement for proposed initial public offering fremont california june    zosano pharma corporation zosano announced today that it has filed a registration statement on form s with the us securities and exchange commission sec for a proposed initial public offering of shares of its common stock all of the shares to be sold in the offering will be offered by zosano the n pdf add to briefcase file is in briefcase jun   zosano pharma inc to present at the th american diabetes association ada scientific session fremont ca  june    zosano pharma inc a privately held biopharmaceutical company developing products based on its novel transdermal delivery technology announced that peter daddona phd chief scientific officer and executive vice president research  development will present data today on its zpglucagon product candida pdf add to briefcase file is in briefcase jun   zosano pharma appoints winnie w tso cpa as chief financial officer fremont calif june    zosano pharma inc a privately held biopharmaceutical company developing products based on its novel transdermal delivery technology today announced the appointment of winnie w tso cpa as chief financial officer with more than  years of finance accounting and strategic management experience in the bi pdf add to briefcase file is in briefcase may   zosano pharma inc to present at the rd international microneedle conference fremont ca  may    zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology announced that dr peter daddona the companys chief scientific officer and executive vice president research  development will present data today on its zpglucagon product  pdf add to briefcase file is in briefcase feb   zosano pharma enters into a license agreement with novo nordisk to deliver semaglutide using zosanos microneedle patch system fremont california february   prnewswire  zosano pharma inc zosano announced today that it has entered into an agreement with novo nordisk as nvo to develop a new transdermal presentation of semaglutide an investigational proprietary human glp glucagonlike peptide analogue to be administered once weekly using zosano pdf add to briefcase file is in briefcase may   zosano pharma inc appoints nandan oza as chief operations officer fremont ca  may    zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology announced today a key addition to its executive team with the appointment of nandan oza as the companys chief operations officer in this position mr oza will guide the compan pdf add to briefcase file is in briefcase apr   zosano pharma inc expands board of directors with addition of kleanthis g xanthopoulos phd fremont ca  april    zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology announced today the appointment of kleanthis g xanthopoulos phd to its board of directors dr xanthopoulos is president  chief executive officer of regulus therapeutics  pdf add to briefcase file is in briefcase apr   zosano pharma inc announces key strategic hire fremont ca  april    zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology announced today that chris krueger has been appointed as the companys chief business officer in this position mr krueger will be responsible for the companys business devel pdf add to briefcase file is in briefcase oct   zosano pharma inc and asahi kasei pharma corporation enter exclusive licensing agreement for a weekly transdermal patch formulation of teribone™ teriparatide acetate for osteoporosis fremont calif and tokyo oct   prnewswire — zosano pharma inc zosano and asahi kasei pharma corporation akp announced today that they have entered into a long–term strategic collaboration for the development commercialization and supply of a weekly transdermal patch formulation of teribone™ teriparatide acet pdf add to briefcase file is in briefcase jan   zosano pharma inc to present at the th annual drug delivery partnerships meeting fremont calif january   – zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology today announced that dr peter daddona the company’s chief scientific officer will present at the th annual drug delivery partnerships meeting in orlando florida  pdf add to briefcase file is in briefcase nov   zosano pharma inc announces publication of positive phase  study of its zppth patch for osteo fremont calif –  november   – zosano pharma inc a privately held pharmaceutical company developing products using  a novel transdermal delivery technology announced publication in the current issue of the journal of clinical endocrinology and metabolism of results from a positive phase  study of its rapid pdf add to briefcase file is in briefcase jul   zosano pharma inc secures  million in new round of financing fremont calif – july   – zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology today announced that the company has closed a new round of financing in the amount of  millionnomura phase ventures led the round and all of the  pdf add to briefcase file is in briefcase jun   zosano pharma inc announces appointment of thorsten von stein as chief medical officer fremont calif – june   – zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology today announced that thorsten von stein md phd has joined the company as chief medical officer  dr von stein reports to zosano chair and ceo gail sc pdf add to briefcase file is in briefcase jun   zosano pharma inc announces appointment of thorsten von stein as chief medical officer fremont calif – june   – zosano pharma inc a privately held pharmaceutical company developing products based on its novel transdermal delivery technology today announced that thorsten von stein md phd has joined the company as chief medical officer  dr von stein reports to zosano chair and ceo gail sc pdf add to briefcase file is in briefcase apr   zosano pharma inc presents positive phase  results of its needlefree osteoporosis therapy fremont calif – april   – zosano pharma inc a privately held pharmaceutical company developing products using  a novel transdermal delivery technology today presented positive results from its phase  study of the zppth rapid delivery patch for the treatment of osteoporosis at the th international symposi pdf add to briefcase file is in briefcase mar   zosano pharma inc to present positive phase  results of its transdermal patch for osteoporosis fremont calif – march   – zosano pharma inc a privately held pharmaceutical company developing products using a novel transdermal delivery technology today announced that an abstract detailing results of its phase  study of zppth a proprietary transdermal patch formulation of parathyroid hormone pth for th pdf add to briefcase file is in briefcase jan   zosano pharma inc to present at the th annual drug delivery partnerships meeting fremont calif january   – zosano pharma inc a privately held pharmaceutical company developing products using a novel transdermal delivery technology today announced that dr peter daddona the company’s chief scientific officer will present at the th annual drug delivery partnerships meeting in las ve pdf add to briefcase file is in briefcase dec   zosano pharma inc announces zosano pharma inc completes positive endofphase  meeting with fda regarding zp pth patch for osteoporosis fremont calif – december   – zosano pharma inc a privately held pharmaceutical company developing products using a novel transdermal delivery technology today announced that it has completed  an  endofphase  meeting with the us food and drug administration fda regarding its zppth rapid delivery pdf add to briefcase file is in briefcase dec   zosano pharma inc completes positive endofphase  meeting with fda regarding zp pth patch fremont calif – december   – zosano pharma inc a privately held pharmaceutical company developing products using a novel transdermal delivery technology today announced that it has completed an endofphase  meeting with the us food and drug administration fda regarding its zppth rapid delivery patch for the treat pdf add to briefcase file is in briefcase oct   zosano pharma inc announces positive results of phase  osteoporosis study fremont calif – october   – zosano pharma inc a privately held pharmaceutical company developing a novel transdermal delivery technology today announced positive results from its phase  randomized multicenter doubleblind multidose study designed to determine safety and efficacy of its zppth rapid deliv pdf add to briefcase file is in briefcase oct   zosano pharma inc to present at bio investor forum fremont calif – october   – zosano pharma inc a privately held pharmaceutical company developing a novel transdermal delivery technology for a broad range of therapeutic indications announced today that john vuko chief financial officer of zosano will present at the th annual bio investor forum mr vuko will pdf add to briefcase file is in briefcase sep   zosano pharma inc announces positive results of phase  trial with pth transdermal patch in osteoporosis fremont calif – september   – zosano pharma inc a privately held pharmaceutical company developing a novel transdermal delivery technology today announced that an abstract detailing results of its phase  study of zosano pth patch a proprietary transdermal patch formulation of parathyroid hormone pth for the tre pdf add to briefcase file is in briefcase sep   zosano pharma inc announces appointment of gail schulze as chair and ceo fremont ca – september   – zosano pharma inc a privately held pharmaceutical company developing a novel transdermal delivery technology today announced that gail schulze has joined the company as chair and ceo the company also announced several recent appointments to the zosano leadership team including don brown  pdf add to briefcase file is in briefcase nov   zosano pharma inc closes enrollment in phase  trial fremont califbusiness wirezosano pharma inc announced today that it has closed enrollment of its phase  clinical trial evaluating a parathyroid hormone hpth  transdermal microprojection delivery system to treat post menopausal women with osteoporosis who are at a high risk of bone fracture this enrollment was completed ahead of pdf add to briefcase file is in briefcase nov   zosano pharma inc announces funding close totaling  million fremont califbusiness wirezosano pharma inc an emerging specialty pharmaceutical company focused on developing better pharmaceutical products using innovative drug delivery has announced the receipt of the second half of its initial venture funding of  million for a total investment of  million four venture capital firms new pdf add to briefcase file is in briefcase sep   macroflux announces name change to zosano pharma inc fremont califbusiness wiresept  the macroflux corporation announced today that it has changed the name of the company to zosano pharma inc our name change reflects the positive evolutionary steps the company is taking to advance our innovative transdermal microprojection delivery system technology said m cory zwerl pdf add to briefcase file is in briefcase may   macroflux names m cory zwerling president ceo macroflux an emerging specialty pharmaceutical company focused on the development of proprietary products has named m cory zwerling president and ceo of the company “this is an exciting opportunity to lead macroflux with a strong team innovative product opportunities and high caliber board” said mr zwerling “the  pdf add to briefcase file is in briefcase oct   launch of macroflux corporation originally a group within alza corporation the macroflux corporation spinout is being led bynomura phase ventures a specialist investor in healthcare the syndicate includes significant investments from new enterprise associates nea and funds managed by hbm partners them financing will enable the company to progress several product opp pdf add to briefcase file is in briefcase  add release to briefcase shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us shareholder tools briefcase printed materials email alerts download snapshot rss feeds print share facebook google linkedin twitter email rss home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies stock information historic stock lookup investment calculator analyst coverage investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc zsannasdaq cm stock quote  zosano pharma corp  bloomberg markets error could not add to watchlist x  watchlist zosano pharma corp zsanus nasdaq cm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  shkreli gives zosano a giant headache  investopedia  penny stocks to watch for march  mobl  investopedia there are currently no news stories for this ticker please check back later  zosano pharma announces outcome of end of phase  meetings with fda  zosano announces inducement grants under nasdaq listing rule c  zosano presents additional data from zotrip study at american headache society demonstrating positive results for pain freedom  zosano to present migraine data at three industryleading conferences  zosano reports first quarter  financial results and announces management changes  zosano pharma to host conference call on first quarter  financial results and provide operational update  zosano announces closing of public offering of common stock and exercise of underwriters’ overallotment option  zosano announces pricing of public offering of common stock  zosano pharma reports fourth quarter and fiscal  financial results and business update  zosano pharma announces mg dose of m its novel transdermal therapeutic meets both coprimary endpoints in the zotrip p there are currently no press releases for this ticker please check back later profile zosano pharma corporation provides biopharmaceutical products and services the company specializes in biopharmaceuticals peptides small water soluble molecules monoclonal antibodies and vaccines fort he treatment of severe osteoporosis address  ardentech courtfremont ca united states phone  website wwwzosanopharmacom executives board members john peter walker interim ceo georgia erbez cfochief business officer hayley lewis senior vpoperations donald j kellerman vpclinical development show more zosano pharma corp  zsan company news at ally invest quotes snapshot  zsanzosano pharma corp zsannasdaqset alertoptionsstreaming chartslast pricenasdaq previous close  last trade as of pm et todays changebid size ask size day low  high  volume ksellbuysnapshotchartsnewsoptionsearningsfundamentalsfinancialsinsiders zosano to present migraine data at three industryleading conferencesback to zsan snapshot share storyam et  globe newswirelatebreaking oral and oral presentations to feature m acute migraine therapy zotrip pivotal trial data selected by headache society and drug delivery meetings fremont calif june   globe newswire  zosano pharma corporation nasdaqzsan a specialty pharmaceutical company that recently established a differentiated safety and efficacy profile in a pivotal trial with its lead product m as an acute treatment for migraine today announced that three conferences have accepted zosano submissions for oral presentation at their annual meetings  zosano will have a latebreaking oral presentation at the american headache society meeting in june as well as an oral presentation at the international headache society meeting in september  in addition zosano has been selected to present at the transdermal and intradermal drug delivery systems conference also in september the selection of our data for oral presentations at these key medical meetings underscores the need for new therapies for migraine patients said don kellerman vice president of clinical development and medical affairs at zosano we believe that it is important to increase awareness of m and its compelling clinical results among key opinion leaders as well as community physicians   the clearly differentiating data from our zotrip trial highlights the potential of our lead migraine product as well as the underlying technology that has made its clinical results possible said john walker zosanos interim ceo and chairman of the board of directors  these presentations offer a forum to present m as a primary treatment option if approved for acute migraine sufferers who seek a therapeutic option that is both fast acting at onset and offers a durable response below is a schedule for the oral presentations conference american headache society ahs th annual scientific meeting presentation title effectiveness and safety of a new zolmitriptan rapid absorption microneedle array m for the acute treatment of migraine the zotrip study date saturday june   am location boston ma westin boston waterfront abstract iorlb conference th congress of the international headache society title comparative effects of  doses of zolmitriptan patch m and placebo on pain and most bothersome symptom for the acute treatment of migraine  the zotrip study date september    am location vancouver canada vancouver convention center abstract ihc conference transdermal and intradermal drug delivery systems  title clinical trial experience with the intracutaneous microneedle systems experience in osteoporosis diabetes and migraine sponsor pharmaed resources inc date september  at pm location philadelphia pa racquet club of philadelphia about migraine migraine is the leading cause of disability among neurological disorders in the united states according to the american migraine foundation migraine symptoms can include moderate to severe headache pain combined with nausea and vomiting or abnormal sensitivity to light and sound  according to the migraine research foundation migraine affects  million men women and children in the united states most migraines last between four and  hours but some last as long as three days according to published studies  of migraine patients experience between one and four migraines per month according to decision resources prescription drug sales for migraine in the top seven countries were estimated to be  billion in  and are expected to grow to  billion in  triptans a family of tryptaminebased drugs first sold in the s account for almost  of antimigraine therapies prescribed at office visits about m m is our proprietary formulation of zolmitriptan coated onto our patented intracutaneous microneedle patch which is then applied with our proprietary applicator to ensure uniform and consistent application in february  the company announced statistically significant results from the zotrip trial which demonstrated that the mg dose of m met both coprimary endpoints achieving pain freedom and most bothersome symptom freedom at  hours  in a phase  trial m demonstrated markedly faster absorption kinetics compared to oral zolmitriptan the company presented these results at the  annual meeting of the american headache society about zosano pharma zosano pharma corporation is an emerging cns company focusing on providing rapid symptom relief to patients using known therapeutics and altering their delivery profile using the companys proprietary intracutaneous delivery system the companys goal is to make intracutaneous drug delivery a standard of care for delivering drugs requiring fast onset of action zosano pharma has developed its proprietary intracutaneous delivery system to administer proprietary formulations of existing drugs through the skin for the treatment of a variety of indications  the company believes that its intracutaneous delivery system offers rapid and consistent drug delivery combined with ease of use the company is focused on developing products that deliver established molecules with known safety and efficacy profiles for markets where patients remain underserved by existing therapies zosano pharma anticipates that many of its current and future development programs may enable the company to utilize a regulatory pathway that would streamline clinical development and accelerate the path towards commercialization learn more at wwwzosanopharmacom   forwardlooking statements this press release contains forwardlooking statements regarding the timing of expected clinical development milestones sufficiency of our capital resources and need for future funding and other future events and expectations readers are urged to consider statements that include the words may will would could should might believes estimates projects potential expects plans anticipates intends continues forecast designed goal unaudited approximately or the negative of those words or other comparable words to be uncertain and forwardlooking these statements are subject to risks and uncertainties that are difficult to predict and actual outcomes may differ materially these include risks and uncertainties without limitation associated with the process of discovering developing and commercializing products that are safe and effective for use as human therapeutics risks inherent in the effort to build a business around such products and other risks and uncertainties described under the heading risk factors in the companys most recent annual report on form k although we believe that the expectations reflected in these forwardlooking statements are reasonable we cannot in any way guarantee that the future results level of activity performance or events and circumstances reflected in forwardlooking statements will be achieved or occur all forwardlooking statements are based on information currently available to zosano and zosano assumes no obligation to update any such forwardlooking statements zosano contact georgia erbez chief business officer and interim chief financial officer  investor contact jamien jones blueprint life science group  x  jjonesbplifesciencecom other top stories zsankeller rohrback llp files complaint against certavibrant health products issues allergy alert on undeimportant equity alert khang  khang llp announces investor alert goldberg law pc announces the filingimportant equity alert lundin law pc announces secu most popular storieszosano to present migraine data at three industrylemidmorning market update markets open higher teva tozosano pharma reports third quarter  financial rzosano pharma announces mg dose of m its novelzosan prices m share offering at sharemost popular keyword searchesnflx goog jcp mjna gpro fnma ddd amzn enter symbol or name fb twtr amd spy baba f znga tsla kkd bac aapl   zosano pharma   ardentech court fremont ca   contact us zosano pharma  ardentech court fremont california   for further information regarding business development interests with zosano pharma please contact business development bdzosanopharmacom about leadership board of directors contact home about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact about leadership board of directors contact migraine technology pipeline publications investors press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings annual reports and proxies key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile investor faqs contact us careers benefits contact terms of use   zosano pharma corporationall rights reserved terms of use website design hane chow inc